The A4 study: Now is the time to join the fight to prevent Alzheimer's disease.

Predicting Amyloid Positivity in Cognitively Unimpaired Older Adults: A Machine Learning Approach Using A4 Data

Petersen KK, Lipton RB, Grober E, Davatzikos C, Sperling RA, Ezzati A. Neurology. 2022;98(24):e2425-e2435.
READ MORE

Association of short and long sleep duration with amyloid-beta burden and cognition in aging

Joseph R Winer 1 , Kacie D Deters 1 , Gabriel Kennedy 1 , Meghan Jin 1 , Andrea Goldstein-Piekarski 2 3 , Kathleen L Poston 1 , Elizabeth C Mormino 1. JAMA Neurol. 2021 Oct; 78(10): 1–10.
READ MORE

Feasibility study for detection of retinal amyloid in clinical trials: The Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial

Ngolab J, Donohue M, Belsha A, et al. Alzheimer’s & dementia: diagnosis, assessment & disease monitoring; Alzheimers Dement (Amst). 2021;13(1):e12199-n/a.
READ MORE

Feasibility Study Conducted for A4 Trial

Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
READ MORE

Your upload was successful!